Clinical actionability of molecular targets in endometrial cancer

ME Urick, DW Bell - Nature Reviews Cancer, 2019 - nature.com
Abstract Endometrial cancer accounts for~ 76,000 deaths among women each year
worldwide. Disease mortality and the increasing number of new diagnoses make …

Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno …

S Hendry, R Salgado, T Gevaert… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …

[HTML][HTML] Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

S Kommoss, MK McConechy, F Kommoss, S Leung… - Annals of …, 2018 - Elsevier
Background We have previously developed and confirmed a pragmatic molecular classifier
for endometrial cancers; ProMisE (Proactive Molecular Risk Classifier for Endometrial …

Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer

A Talhouk, MK McConechy, S Leung, W Yang, A Lum… - Cancer, 2017 - Wiley Online Library
BACKGROUND Classification of endometrial carcinomas (ECs) by morphologic features is
irreproducible and imperfectly reflects tumor biology. The authors developed the Proactive …

Interpretation of somatic POLE mutations in endometrial carcinoma

A León‐Castillo, H Britton… - The Journal of …, 2020 - Wiley Online Library
Pathogenic somatic missense mutations within the DNA polymerase epsilon (POLE)
exonuclease domain define the important subtype of ultramutated tumours ('POLE …

POLE/POLD1 mutation and tumor immunotherapy

X Ma, L Dong, X Liu, K Ou, L Yang - Journal of Experimental & Clinical …, 2022 - Springer
POLE and POLD1 encode the catalytic and proofreading subunits of DNA polymerase ε and
polymerase δ, and play important roles in DNA replication and proofreading. POLE/POLD1 …

A clinically applicable molecular-based classification for endometrial cancers

A Talhouk, MK McConechy, S Leung… - British journal of …, 2015 - nature.com
Background: Classification of endometrial carcinomas (ECs) by morphologic features is
inconsistent, and yields limited prognostic and predictive information. A new system for …

New concepts for an old problem: the diagnosis of endometrial hyperplasia

PA Sanderson, HOD Critchley… - Human reproduction …, 2017 - academic.oup.com
BACKGROUND Endometrial hyperplasia (EH) is a uterine pathology representing a
spectrum of morphological endometrial alterations. It is predominantly characterized by an …

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

J Huvila, J Pors, EF Thompson… - The Journal of …, 2021 - Wiley Online Library
Endometrial carcinoma (EC) is classified into a wide range of morphological variants; this list
has expanded over the past decade with the inclusion of mesonephric‐like and …

A panoply of errors: polymerase proofreading domain mutations in cancer

E Rayner, IC Van Gool, C Palles, SE Kearsey… - Nature Reviews …, 2016 - nature.com
Although it has long been recognized that the exonucleolytic proofreading activity intrinsic to
the replicative DNA polymerases Pol δ and Pol ε is essential for faithful replication of DNA …